7487 Results

People

  1. Brennan
    Brennan
  2. Danishefsky
    Danishefsky
  3. Larson
    Larson
  4. Scheinberg
    Scheinberg
  5. Fuks
    Fuks
  6. Rosen
    Rosen
  7. Hricak
    Hricak
  8. Pasternak
    Pasternak
  9. Sadelain
    Sadelain
  10. Scardino
    Scardino

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)
  7. Radiology, Department of (1814)
  8. Hematologic Malignancies Research (1617)
  9. Hematologic Malignancies, Division of (1517)
  10. Center for Molecular Imaging and Biotechnology (1341)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activating alterations of p110 subunits determine PI3K isoform selectivity in prostate cancer
    Meeting Abstract

    Zhang, Z.; Mao, N.; Lee, Y. S.; Li, D.; Rosen, N.; Sawyers, C.; Carver, B.
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Self-Assembling and DisAssembling bispecific antibodies for curative 2-step pretargeted radioimmunotherapy
    Meeting Abstract

    Santich, B.; Cheal, S.; Ahmed, M.; McDevitt, M.; Ouerfelli, O.; Veach, D.; Fung, E.; Burnes Vargas, D.; Malik, A.; Guo, H. F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • GT3-Nano based radioprotector drug promotes rapid recovery from (153)Sm-EDTMP induced myelotoxcity
    Meeting Abstract

    Lee, S. G.; Kalidindi, T. M.; Punzalan, B.; Pillarsetty, N.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Novel radioiodinated theranostic agent targeting PSMA for prostate cancer
    Meeting Abstract

    Kalidindi, T. M.; Lee, S. G.; Lewis, J.; Larson, S.; Pillarsetty, N.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Effect of reducing specific activity of [(177)Lu]-DKFZ-PSMA617 on uptake in the tumor, salivary gland and kidney
    Meeting Abstract

    Kalidindi, T. M.; Lee, S. G.; Punzalan, B.; Veach, D.; Jou, K.; Chakraborty, G.; Tagawa, S.; Bander, N.; Lewis, J.; Larson, S.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Multicycle pretargeted radioimmunotherapy using 177(Lu) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; Punzalan, B.; Veach, D.; Xu, H.; Guo, H. F.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted radioimmunotherapy using 225(Ac) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; McDevitt, M.; Xu, H.; Guo, H. F.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted alpha radioimmunotherapy (DOTA-PRIT) for HER2-expressing human gastric cancer: A theranostic approach using 111(In)/225(Ac)-radiohapten
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • (225)Ac-alpha pretargeted radioimmunotherapy (DOTA-PRIT) of human colorectal cancer: Achieving 100% complete responses with single-cycle targeting of 2 distinct antigens, HER2 and GPA33
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • First-in-human trial of epichaperome-targeted PET in patients with cancer
    Journal Article

    Dunphy, M. P. S.; Pressl, C.; Pillarsetty, N.; Grkovski, M.; Modi, S.; Jhaveri, K.; Norton, L.; Beattie, B. J.; Zanzonico, P. B.; Zatorska, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save